封面
市場調查報告書
商品編碼
1534167

全球透明質酸原料市場規模研究,按應用、按來源、按等級和區域預測 2022-2032

Global Hyaluronic Acid Raw Material Market Size study, by Application, by Source, by Grade and Regional Forecasts 2022-2032

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 285 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年全球透明質酸原料市場規模估計為66.1億美元,預計2024年至2032年將以6.5%的年複合成長率(CAGR)成長。 ,特別是在關節炎和整容手術治療方面。在越來越多的批准治療產品的推動下,這些材料在骨關節炎治療中的使用不斷增加,促進了市場的成長。關節炎病例的增加增強了透明質酸在相關治療中的接受度,進一步加速了市場擴張。

此外,市場對整容手術治療中的透明質酸原料的需求激增。糖尿病患者的慢性傷口和整形外科手術需求的不斷成長對透明質酸製劑產生了巨大的需求。玻尿酸獨特的保濕和黏彈性特性正在推動其在抗衰老治療、臉部線條矯正和臉頰增大過程中的應用。 FDA 批准使用透明質酸進行真皮填充劑來矯正細紋和皺紋,這也有助於這些材料的銷量增加,因為它們的過敏反應風險極低。然而,由於透明質酸原料成本較高,市場面臨挑戰,這限制了資金緊張的終端用戶的取得。此外,搔癢和血管閉塞等副作用也限制了它們的需求。

從地區來看,北美在 2023 年佔據市場主導地位,收入佔有率最大,達 40.9%。這一重要佔有率歸功於先進的技術、先進的醫療基礎設施以及患者對美容和抗衰老手術意識的提高。該地區對微創整容手術的需求預計將推動進一步擴張。同時,亞太地區預計在預測期內將以 9.0% 的複合年成長率最快成長。該地區強大的護膚和美容文化,加上人們對日常護膚意識的不斷提高,正在推動對以其保濕和抗衰老特性而聞名的透明質酸的需求。

目錄

第1章:全球透明質酸原料市場執行摘要

  • 全球玻尿酸原料市場規模及預測(2022-2032)
  • 區域概要
  • 分部摘要
    • 按申請
    • 按來源
    • 按年級
  • 主要趨勢
  • 經濟衰退的影響
  • 分析師推薦與結論

第 2 章:全球透明質酸原料市場定義與研究假設

  • 研究目的
  • 市場定義
  • 研究假設
    • 包容與排除
    • 限制
    • 供給側分析
      • 可用性
      • 基礎設施
      • 監管環境
      • 市場競爭
      • 經濟可行性(消費者的角度)
    • 需求面分析
      • 監理框架
      • 技術進步
      • 環境考慮
      • 消費者意識和接受度
  • 估算方法
  • 研究涵蓋的年份
  • 貨幣兌換率

第3章:全球玻尿酸原料市場動態

  • 市場促進因素
    • 關節炎治療的消費不斷成長
    • 擴大在整容手術中使用
  • 市場挑戰
    • 高價
    • 副作用
  • 市場機會
    • 加大透明質酸研發力度
    • 不斷成長的醫療保健支出

第4章:全球透明質酸原料市場產業分析

  • 波特的五力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭競爭
    • 波特五力模型的未來方法
    • 波特的五力影響分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會的
    • 技術性
    • 環境的
    • 合法的
  • 頂級投資機會
  • 最佳制勝策略
  • 顛覆性趨勢
  • 產業專家視角
  • 分析師推薦與結論

第 5 章:全球透明質酸原料市場規模及預測:依應用分類 - 2022-2032

  • 細分儀表板
  • 全球透明質酸原料市場:2022年及2032年應用收入趨勢分析
    • 眼科
    • 骨科
    • 皮膚科
    • 藥物輸送
    • 醫療器材塗層
    • 手術沾黏的預防
    • 生物材料和植入物
    • 細胞和組織保存

第 6 章:全球玻尿酸原料市場規模及預測:依來源分類 - 2022-2032

  • 細分儀表板
  • 全球透明質酸原料市場:2022年及2032年來源收入趨勢分析
    • 非動物
    • 動物

第 7 章:全球玻尿酸原料市場規模及預測:依等級 - 2022-2032

  • 細分儀表板
  • 全球透明質酸原料市場:2022年及2032年等級收入趨勢分析
    • 製藥
    • 化妝品
    • 骨科

第 8 章:全球透明質酸原料市場規模及預測:按地區 - 2022-2032

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 中東和非洲其他地區

第 9 章:競爭情報

  • 重點企業SWOT分析
  • 頂級市場策略
  • 公司簡介
    • AbbVie Inc.
      • 關鍵訊息
      • 概述
      • 財務(視數據可用性而定)
      • 產品概要
      • 市場策略
    • Salix Pharmaceuticals
    • Lifecore Biomedical, Inc.
    • Sanofi
    • Anika Therapeutics, Inc.
    • Zimmer Biomet
    • Smith+Nephew
    • LG Chem
    • Maruha Nichiro Corporation
    • Ferring BV

第 10 章:研究過程

  • 研究過程
    • 資料探勘
    • 分析
    • 市場預測
    • 驗證
    • 出版
  • 研究屬性
簡介目錄

The global hyaluronic acid raw material market size was estimated at USD 6.61 billion in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2032. Hyaluronic acid raw materials are gaining significant traction across various applications, particularly in arthritis and cosmetic surgery treatments. The growing use of these materials in the treatment of osteoarthritis is contributing to market growth, driven by an increasing number of approved therapeutic products. The rise in arthritis cases is bolstering the acceptance of hyaluronic acid in related treatments, further accelerating market expansion.

Additionally, the market is witnessing a surge in demand for hyaluronic acid raw materials in cosmetic surgery treatments. Chronic wounds among diabetic patients and the rising demand for plastic surgery procedures are generating significant requirements for agents based on hyaluronic acid. The unique moisturizing and viscoelastic properties of hyaluronic acid are driving its use in anti-aging treatments, facial line corrections, and cheek augmentation processes. FDA approval for dermal fillers using hyaluronic acid for fine line and wrinkle correction is also contributing to the increased sales of these materials, driven by their minimal risk of allergic reactions. However, the market faces challenges due to the high cost of hyaluronic acid raw materials, which limits their accessibility for end users with monetary constraints. Additionally, side effects such as itching and vascular occlusion are restricting their demand.

Regionally, North America dominated the market in 2023, holding the largest revenue share of 40.9%. This significant share is attributed to advanced technologies, a sophisticated healthcare infrastructure, and increasing patient awareness of aesthetic and anti-aging procedures. The region's demand for minimally invasive cosmetic procedures is expected to drive further expansion. Meanwhile, the Asia Pacific region is anticipated to grow at the fastest CAGR of 9.0% during the forecast period. The region's strong skincare and beauty culture, coupled with increasing awareness of skincare routines, is driving the demand for hyaluronic acid, known for its moisturizing and anti-aging properties.

Major market players included in this report are:

  • AbbVie Inc.
  • Salix Pharmaceuticals
  • Lifecore Biomedical, Inc.
  • Sanofi
  • Anika Therapeutics, Inc.
  • Zimmer Biomet
  • Smith+Nephew
  • LG Chem
  • Maruha Nichiro Corporation
  • Ferring B.V.

The detailed segments and sub-segment of the market are explained below:

By Application:

  • Ophthalmology
  • Orthopedics
  • Dermatology
  • Drug Delivery
  • Medical Device Coating
  • Surgical Adhesion Prevention
  • Biomaterials and Implants
  • Cell and Tissue Preservation

By Source:

  • Non-Animal
  • Animal

By Grade:

  • Pharmaceutical
  • Cosmetic
  • Orthopedic

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market

Table of Contents

Chapter 1. Global Hyaluronic Acid Raw Material Market Executive Summary

  • 1.1. Global Hyaluronic Acid Raw Material Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Application
    • 1.3.2. By Source
    • 1.3.3. By Grade
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Hyaluronic Acid Raw Material Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Hyaluronic Acid Raw Material Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Growing Consumption in Arthritis Treatments
    • 3.1.2. Increasing Use in Cosmetic Surgery
  • 3.2. Market Challenges
    • 3.2.1. High Prices
    • 3.2.2. Side Effects
  • 3.3. Market Opportunities
    • 3.3.1. Increasing R&D for Hyaluronic Acid
    • 3.3.2. Growing Healthcare Spending

Chapter 4. Global Hyaluronic Acid Raw Material Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Hyaluronic Acid Raw Material Market Size & Forecasts by Application 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Hyaluronic Acid Raw Material Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 5.2.1. Ophthalmology
    • 5.2.2. Orthopedics
    • 5.2.3. Dermatology
    • 5.2.4. Drug Delivery
    • 5.2.5. Medical Device Coating
    • 5.2.6. Surgical Adhesion Prevention
    • 5.2.7. Biomaterials and Implants
    • 5.2.8. Cell and Tissue Preservation

Chapter 6. Global Hyaluronic Acid Raw Material Market Size & Forecasts by Source 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Hyaluronic Acid Raw Material Market: Source Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 6.2.1. Non-Animal
    • 6.2.2. Animal

Chapter 7. Global Hyaluronic Acid Raw Material Market Size & Forecasts by Grade 2022-2032

  • 7.1. Segment Dashboard
  • 7.2. Global Hyaluronic Acid Raw Material Market: Grade Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 7.2.1. Pharmaceutical
    • 7.2.2. Cosmetic
    • 7.2.3. Orthopedic

Chapter 8. Global Hyaluronic Acid Raw Material Market Size & Forecasts by Region 2022-2032

  • 8.1. North America Hyaluronic Acid Raw Material Market
    • 8.1.1. U.S. Hyaluronic Acid Raw Material Market
      • 8.1.1.1. Application breakdown size & forecasts, 2022-2032
      • 8.1.1.2. Source breakdown size & forecasts, 2022-2032
      • 8.1.1.3. Grade breakdown size & forecasts, 2022-2032
    • 8.1.2. Canada Hyaluronic Acid Raw Material Market
  • 8.2. Europe Hyaluronic Acid Raw Material Market
    • 8.2.1. U.K. Hyaluronic Acid Raw Material Market
    • 8.2.2. Germany Hyaluronic Acid Raw Material Market
    • 8.2.3. France Hyaluronic Acid Raw Material Market
    • 8.2.4. Spain Hyaluronic Acid Raw Material Market
    • 8.2.5. Italy Hyaluronic Acid Raw Material Market
    • 8.2.6. Rest of Europe Hyaluronic Acid Raw Material Market
  • 8.3. Asia-Pacific Hyaluronic Acid Raw Material Market
    • 8.3.1. China Hyaluronic Acid Raw Material Market
    • 8.3.2. India Hyaluronic Acid Raw Material Market
    • 8.3.3. Japan Hyaluronic Acid Raw Material Market
    • 8.3.4. Australia Hyaluronic Acid Raw Material Market
    • 8.3.5. South Korea Hyaluronic Acid Raw Material Market
    • 8.3.6. Rest of Asia Pacific Hyaluronic Acid Raw Material Market
  • 8.4. Latin America Hyaluronic Acid Raw Material Market
    • 8.4.1. Brazil Hyaluronic Acid Raw Material Market
    • 8.4.2. Mexico Hyaluronic Acid Raw Material Market
    • 8.4.3. Rest of Latin America Hyaluronic Acid Raw Material Market
  • 8.5. Middle East & Africa Hyaluronic Acid Raw Material Market
    • 8.5.1. Saudi Arabia Hyaluronic Acid Raw Material Market
    • 8.5.2. South Africa Hyaluronic Acid Raw Material Market
    • 8.5.3. Rest of Middle East & Africa Hyaluronic Acid Raw Material Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. AbbVie Inc.
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Market Strategies
    • 9.3.2. Salix Pharmaceuticals
    • 9.3.3. Lifecore Biomedical, Inc.
    • 9.3.4. Sanofi
    • 9.3.5. Anika Therapeutics, Inc.
    • 9.3.6. Zimmer Biomet
    • 9.3.7. Smith+Nephew
    • 9.3.8. LG Chem
    • 9.3.9. Maruha Nichiro Corporation
    • 9.3.10. Ferring B.V.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes